Tema Cardiovascular and Metabolics ETF Rating → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free HRTS Stock Alerts $31.92 +0.24 (+0.76%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsRatingsTrendsStock AnalysisChartHeadlinesHoldingsRatingsTrends Tema Cardiovascular and Metabolics ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy2.75Holdings in HRTS have an aggregate rating of Moderate Buy based on 425 analyst ratings issued in the past year covering 39 companies (86.4% of the portfolio).HRTS Aggregate Price Target$49.2454.25% UpsideHigh Prediction$66.88Average Prediction$49.24Low Prediction$32.86Holdings in HRTS have an aggregate price target of $49.24 and a range of $32.86 to $66.88 covering 39 companies (86.4% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 HRTS Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.04%VRTXVertex Pharmaceuticals$455.34+2.8%4 of 5 stars2.50$438.62 -3.7%24Analyst ForecastInsider SellingNews CoverageHigh Trading Volume5.56%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑5.25%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling4.18%DXCMDexCom$118.77+0.3%5 of 5 stars2.87$140.94 18.7%15Analyst ForecastShort Interest ↓High Trading Volume3.16%EWEdwards Lifesciences$86.89-1.1%5 of 5 stars2.65$95.06 9.4%20Analyst ForecastInsider SellingShort Interest ↓High Trading Volume3.08%CRNXCrinetics Pharmaceuticals$44.41-2.1%4 of 5 stars2.92$60.92 37.2%12Insider Selling2.96%NARIInari Medical$50.00-1.4%3 of 5 stars2.71$65.71 31.4%7Insider SellingNews Coverage2.90%PODDInsulet$177.19+0.7%5 of 5 stars2.83$239.18 35.0%18Analyst ForecastInsider SellingShort Interest ↑2.86%MDTMedtronic$81.37+1.0%5 of 5 stars2.25$93.00 14.3%12Analyst Forecast2.75%ALNYAlnylam Pharmaceuticals$148.43-1.1%5 of 5 stars2.59$216.19 45.6%17Insider SellingHigh Trading Volume2.73%BBIOBridgeBio Pharma$28.01-2.9%5 of 5 stars2.92$47.62 70.0%12Analyst ForecastAnalyst Revision2.71%BSXBoston Scientific$75.57+0.8%5 of 5 stars2.95$76.70 1.5%22Analyst ForecastInsider SellingShort Interest ↓2.70%RAREUltragenyx Pharmaceutical$40.14+3.9%5 of 5 stars2.93$90.67 125.9%14Analyst ForecastNews CoverageGap UpHigh Trading Volume2.47%NTLAIntellia Therapeutics$21.38-3.3%4 of 5 stars2.69$66.77 212.3%13Analyst RevisionPositive News2.41%MREOMereo BioPharma Group$3.45-3.9%3 of 5 stars3.00$6.50 88.4%2Short Interest ↓News Coverage2.39%RCKTRocket Pharmaceuticals$21.32-0.6%4 of 5 stars2.89$52.13 144.5%92.33%MASIMasimo$124.50-1.3%5 of 5 stars2.43$138.71 11.4%7Short Interest ↓Analyst RevisionPositive News2.19%CYTKCytokinetics$48.51-1.2%4 of 5 stars2.82$74.88 54.4%17Analyst Forecast2.06%ARWRArrowhead Pharmaceuticals$22.95+0.7%4 of 5 stars2.78$51.00 122.2%9Gap Up2.05%WSTWest Pharmaceutical Services$331.41+0.7%5 of 5 stars2.80$435.20 31.3%5Positive News2.03%BMYBristol-Myers Squibb$41.09+2.1%5 of 5 stars2.11$60.00 46.0%19High Trading Volume1.97%IONSIonis Pharmaceuticals$37.57+2.8%4 of 5 stars2.71$59.54 58.5%14Positive News1.95%ASNDAscendis Pharma A/S$135.10-1.7%3 of 5 stars2.89$179.44 32.8%9Analyst ForecastShort Interest ↓Positive News1.81%VKTXViking Therapeutics$62.26+0.8%4 of 5 stars3.11$112.38 80.5%9Analyst UpgradePositive NewsGap Down1.71%OMCLOmnicell$32.59-0.2%3 of 5 stars2.33$42.20 29.5%6Short Interest ↓Positive News1.51%MLYSMineralys Therapeutics$12.77+2.8%3 of 5 stars3.00$33.50 162.3%3Positive News1.50%MDGLMadrigal Pharmaceuticals$236.16+4.7%5 of 5 stars2.73$345.09 46.1%11Positive News1.49%KROSKeros Therapeutics$46.87+1.2%2 of 5 stars3.00$86.00 83.5%7News Coverage1.47%OSCROscar Health$19.96+0.6%3 of 5 stars2.75$18.57 -7.0%8Analyst ForecastShort Interest ↓News Coverage1.46%MIRMMirum Pharmaceuticals$24.03-1.7%4 of 5 stars3.10$49.73 106.9%101.25%ARCTArcturus Therapeutics$38.81+0.9%3 of 5 stars3.00$64.86 67.1%7Short Interest ↓1.13%SLNSilence Therapeutics$20.99-3.8%2 of 5 stars3.00$57.25 172.7%4Analyst ForecastShort Interest ↑News Coverage1.04%AKROAkero Therapeutics$18.82+2.8%4 of 5 stars2.88$41.13 118.5%80.94%TNYATenaya Therapeutics$4.21+0.7%3 of 5 stars3.00$15.00 256.3%7Analyst RevisionNews Coverage0.74%SLNOSoleno Therapeutics$42.08-1.3%4 of 5 stars3.14$60.33 43.4%7Positive News0.67%GPCRStructure Therapeutics$34.20+1.3%2 of 5 stars3.00$83.13 143.1%70.38%VERVVerve Therapeutics$5.19+1.0%2 of 5 stars2.75$33.00 535.8%8News Coverage0.29%SKYESkye Bioscience$11.61-0.3%1 of 5 stars3.00$22.00 89.5%3High Trading Volume0.29%SKYESkye Bioscience$11.61-0.3%1 of 5 stars3.00$22.00 89.5%3High Trading Volume This page (NASDAQ:HRTS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
